← Back to patent-cliff list
[68-Ga]CBP-8
Tier C — Watch / trade[68-Ga]CBP-8
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
-
Type
Targets：Collagen
Indications (approved)：Amyloidosis, Pulmonary fibrosis, Interstitial lung disease, 放射性肺炎, Lung cancer, 肺损伤, Fibrosis, Pancreatic cancer
Regional status
US
Phase III
2023-01-03
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of [68-Ga]CBP-8?
Approved indications include: Amyloidosis, Pulmonary fibrosis, Interstitial lung disease, 放射性肺炎, Lung cancer, 肺损伤, Fibrosis, Pancreatic cancer.
When does the [68-Ga]CBP-8 patent expire?
No public expiry year is available for [68-Ga]CBP-8 yet; this page updates once verified.
How do I get a quote for [68-Ga]CBP-8 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-21